Comprehensive medication guide to NuvaRing including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0 copay for ACA-covered generic vaginal ring (EluRyng or equivalent) on most non-grandfathered plans; brand NuvaRing may require a copay or prior authorization if the insurer covers a generic as the preferred alternative.
Estimated Cash Pricing
$150–$238 retail for brand NuvaRing; generic EluRyng/EnilloRing available for $45–$112 for a 30-day supply; as low as $37–$48 with GoodRx or SingleCare coupons at participating pharmacies.
Medfinder Findability Score
80/100
Summarize with AI
On this page
NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) is a prescription combination hormonal contraceptive used to prevent pregnancy in females of reproductive age. It is a flexible, transparent, latex-free ring that is inserted into the vagina for three weeks, then removed for one ring-free week before a new ring is inserted.
Each NuvaRing contains 11.7 mg of etonogestrel (a progestin) and 2.7 mg of ethinyl estradiol (an estrogen), releasing 0.120 mg/day and 0.015 mg/day respectively over three weeks of use. NuvaRing was first FDA-approved in 2001 and manufactured by Organon (now marketed by Advanz Pharma US Corp). Three generic versions — EluRyng, EnilloRing, and Haloette — are also available.
NuvaRing is highly effective when used correctly, with approximately 98% effectiveness with perfect use and 93% effectiveness with typical use. It does not protect against sexually transmitted infections (STIs) including HIV/AIDS.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
NuvaRing works primarily by suppressing ovulation. The ring releases a continuous, steady dose of etonogestrel and ethinyl estradiol through the vaginal wall into the bloodstream via transmucosal absorption. These hormones suppress the release of FSH and LH from the pituitary gland — the signals that trigger egg development and release. Without ovulation, fertilization cannot occur.
Secondary mechanisms provide additional protection: the progestin thickens cervical mucus (making sperm penetration harder) and alters the endometrial lining. NuvaRing delivers the lowest estrogen dose of any combination hormonal contraceptive available, as the vaginal absorption route achieves effective hormone levels with smaller quantities than oral administration.
Unlike daily birth control pills, which create hormone peaks and troughs, NuvaRing releases hormones at a constant rate — providing more stable blood hormone levels throughout the month. This consistency may result in fewer hormonal fluctuation-related side effects for some users.
0.120 mg/day etonogestrel + 0.015 mg/day ethinyl estradiol — vaginal ring
One ring inserted vaginally for 3 weeks, removed for 1 ring-free week; cycle repeats monthly
As of 2026, NuvaRing and its generics are not listed on the FDA Drug Shortages Database or the ASHP shortage list — there is no declared national shortage. However, individual pharmacy locations may periodically run out of specific brand or generic variants due to stocking decisions, formulary transitions, and regional distribution patterns.
The introduction of three FDA-approved generics (EluRyng, EnilloRing, Haloette) since 2019 has significantly improved overall supply resilience. Large-volume chain pharmacies generally maintain the most consistent stock. Patients who ask about generics and allow brand-or-generic substitution on their prescription experience far fewer access issues.
If you're having trouble locating NuvaRing at your pharmacy, medfinder can call pharmacies near you to check which ones have it in stock — saving you hours of phone calls. Results are texted to you.
NuvaRing is not a controlled substance and has no special DEA scheduling or prescribing requirements. Any licensed healthcare provider authorized to prescribe medications in their state can prescribe NuvaRing, including via telehealth. Prescriptions can be issued for up to a 90-day supply.
OBGYNs (Obstetricians/Gynecologists)
Primary care physicians (PCPs / family medicine doctors)
Nurse practitioners (NPs)
Physician assistants (PAs)
Planned Parenthood and Title X family planning clinic providers
Telehealth providers licensed in your state
Telehealth platforms including Nurx, Planned Parenthood Direct, Wisp, and PRJKT RUBY can prescribe NuvaRing (or generic equivalents) and arrange direct home delivery through partner pharmacies in most U.S. states — often within the same day as the appointment.
No. NuvaRing (etonogestrel/ethinyl estradiol) is not a controlled substance and is not scheduled under the DEA Controlled Substances Act. There are no special prescribing restrictions, no DEA registration required for prescribers, and no limits on refills beyond standard prescription duration.
Any licensed healthcare provider — including nurse practitioners, physician assistants, and telehealth providers — can prescribe NuvaRing in all U.S. states without special authorization. Prescriptions can be issued for up to a 90-day (3-ring) supply. NuvaRing can also be phoned in or e-prescribed, and is available at all major retail pharmacies, mail-order pharmacies, and through telehealth-linked pharmacy services.
In clinical trials, the most commonly reported side effects of NuvaRing (occurring in 5-14% of users) include:
Vaginitis or vaginal irritation (14.1%)
Headache or migraine (9.8%)
Nausea (5.2%)
Mood changes, depression, or decreased libido
Weight changes (4.9% reported weight gain)
Breakthrough bleeding or spotting (2-6.4% of users)
Ring expulsion, foreign body sensation, or discomfort during intercourse (2.5%)
Blood clots (venous thromboembolism) — 6.5x increased risk vs. non-users
Stroke or heart attack (especially in smokers over 35)
Liver tumors or liver disease (jaundice)
Severe allergic reaction (anaphylaxis or angioedema)
Sudden vision changes (possible retinal vein thrombosis)
Know what you need? Skip the search.
EluRyng
FDA-approved generic of NuvaRing with identical hormone content; typically less expensive than brand
Annovera
Year-long reusable vaginal ring (segesterone acetate/ethinyl estradiol) — 13 cycles per ring; different progestin from NuvaRing
Xulane Patch
Weekly contraceptive skin patch (norelgestromin/ethinyl estradiol); similar efficacy to NuvaRing; higher estrogen exposure
Combined Oral Contraceptives
Daily birth control pills; same hormonal class; widely available generics under $15/month; requires daily adherence
Nexplanon
Etonogestrel arm implant lasting up to 3 years; progestin-only; no estrogen; highly effective with no user action required
Prefer NuvaRing? We can find it.
Ombitasvir/paritaprevir/ritonavir (Hepatitis C combination)
majorCONTRAINDICATED — causes serious ALT elevation (liver toxicity). NuvaRing must be stopped before starting this HCV regimen and can be restarted 2 weeks after completion.
Rifampin / Rifabutin
majorStrong CYP3A4 inducers that significantly reduce NuvaRing hormone levels, potentially making it less effective at preventing pregnancy. Use backup contraception.
Anticonvulsants (carbamazepine, phenytoin, topiramate, phenobarbital, felbamate)
majorCYP3A4 inducers that reduce NuvaRing effectiveness. Discuss alternative contraception with provider. Lamotrigine levels may also be reduced by NuvaRing.
HIV antiretrovirals (ritonavir, nelfinavir, lopinavir, darunavir)
majorCan both increase and decrease NuvaRing hormone levels depending on the specific agent. Use backup contraception and discuss with HIV specialist.
St. John's Wort (Hypericum perforatum)
majorPopular herbal supplement that is a strong CYP3A4 inducer; can significantly reduce NuvaRing effectiveness. Avoid concurrent use.
Vaginal miconazole nitrate
moderateCommon antifungal for yeast infections; can increase serum NuvaRing hormone levels by up to 40%. Not typically dangerous but worth monitoring.
CYP3A4 inhibitors (itraconazole, fluconazole, ketoconazole, grapefruit)
moderateCan increase plasma etonogestrel and ethinyl estradiol concentrations. Avoid regular grapefruit consumption with NuvaRing.
Atorvastatin
minorCo-administration may increase ethinyl estradiol AUC by approximately 20-25%. Usually not clinically significant.
NuvaRing is a highly effective, low-maintenance birth control option that works well for people who want reliable hormonal contraception without the daily pill routine. With the availability of FDA-approved generics (EluRyng, EnilloRing, Haloette) since 2019, both access and affordability have improved significantly — with generics available for as low as $37-$45 per month with discount coupons.
NuvaRing is not in a declared shortage as of 2026, but some patients may encounter localized stock-outs at individual pharmacies. Being flexible about brand vs. generic, checking multiple pharmacies, and considering mail-order pharmacy are the best strategies for avoiding gaps in access.
If you're having trouble locating NuvaRing at your pharmacy, medfinder can search pharmacies near you and send you the results by text — so you can go directly to a pharmacy that has it in stock.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards